--- title: "Launch Readiness, Definition | MedTech Terms" description: "Cross-functional checklist confirming a product is ready for commercial release. Plain-English Commercialization definition for MedTech teams, with examples and" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/launch-readiness#term", "name": "Launch Readiness", "description": "Launch readiness is the structured cross-functional gate that confirms a device is ready for commercial release - regulatory clearance, QMS state, supply capacity, sales training, KOL engagement, reimbursement strategy, and post-market surveillance plan.", "url": "https://medtechterms.com/terms/launch-readiness", "termCode": "launch-readiness", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/launch-readiness#article", "headline": "Launch Readiness", "description": "Cross-functional checklist confirming a product is ready for commercial release.", "url": "https://medtechterms.com/terms/launch-readiness", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/launch-readiness" }, "about": { "@id": "https://medtechterms.com/terms/launch-readiness#term" }, "articleSection": "Commercialization", "inLanguage": "en", "keywords": "Launch Readiness, Commercialization, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "AdvaMed product launch", "url": "https://www.advamed.org/", "publisher": { "@type": "Organization", "name": "AdvaMed" } }, { "@type": "CreativeWork", "name": "AdvaMed Code of Ethics", "url": "https://www.advamed.org/our-work/code-of-ethics/", "publisher": { "@type": "Organization", "name": "AdvaMed" } }, { "@type": "CreativeWork", "name": "AHRMM - Healthcare Supply Chain", "url": "https://www.ahrmm.org/", "publisher": { "@type": "Organization", "name": "AHRMM" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/design-history-file#term", "name": "Design History File", "alternateName": "DHF", "url": "https://medtechterms.com/terms/design-history-file" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/post-market-surveillance#term", "name": "Post-Market Surveillance", "alternateName": "PMS", "url": "https://medtechterms.com/terms/post-market-surveillance" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Commercialization", "item": "https://medtechterms.com/terms?cat=Commercialization" }, { "@type": "ListItem", "position": 4, "name": "Launch Readiness", "item": "https://medtechterms.com/terms/launch-readiness" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/launch-readiness#faq", "mainEntity": [ { "@type": "Question", "name": "How does launch readiness relate to a Quality Management System (QMS)?", "acceptedAnswer": { "@type": "Answer", "text": "Launch readiness heavily relies on a mature QMS that ensures all design, manufacturing, and post-market activities comply with regulatory requirements. A QMS provides the documented processes and controls necessary to consistently produce safe and effective devices, which is a prerequisite for market entry." } }, { "@type": "Question", "name": "What role does risk management play in launch readiness?", "acceptedAnswer": { "@type": "Answer", "text": "Risk management, as outlined in ISO 14971:2019, is integral to launch readiness by ensuring that risks associated with the device's use are identified, evaluated, controlled, and monitored throughout its lifecycle. This includes assessing risks related to manufacturing, post-market surveillance, and cybersecurity, all of which must be addressed before launch." } }, { "@type": "Question", "name": "Is launch readiness a one-time event?", "acceptedAnswer": { "@type": "Answer", "text": "Launch readiness is typically a gate preceding market entry, but the underlying activities and considerations are continuous. Post-market surveillance, regulatory compliance updates, and ongoing supply chain management are perpetual activities that evolve even after initial launch." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Commercialization](/terms?cat=Commercialization) 6. / 7. Launch Readiness [All terms](/terms) Commercialization [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) # Launch Readiness Cross-functional checklist confirming a product is ready for commercial release. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition Launch readiness is the structured cross-functional gate that confirms a device is ready for commercial release - regulatory clearance, QMS state, supply capacity, sales training, [KOL](/terms/kol) engagement, reimbursement strategy, and [post-market surveillance plan](/terms/pms-plan). What the regulation says Regulators do not explicitly define "Launch Readiness" as a distinct regulatory gate; however, they require manufacturers to demonstrate compliance across various regulatory domains prior to placing a device on the market. For instance, the FDA mandates pre-market approval or clearance (21 CFR Part 807, 21 CFR Part 814), and the EU [MDR](/terms/mdr-reporting) (Regulation (EU) 2017/745) requires conformity assessment and CE marking. Manufacturers must also maintain a robust Quality Management System (QMS), as per 21 CFR Part 820 or [ISO 13485](/terms/iso-13485):2016, and have a [post-market surveillance plan](/terms/pms-plan) in place, specified in EU MDR Annex III or FDA’s [post-market surveillance](/terms/post-market-surveillance) regulations (21 CFR Part 822). ## What this means in practice Missing any one element can stall launch. CMO, CCO, and Quality VP typically co-own the gate. ## Examples - Before launching a new Class II cardiovascular device, a manufacturer ensured all 510(k) requirements were met, production lines were validated according to 21 CFR 820.75, and a comprehensive sales training program was completed. - A European MedTech company verified that its new in vitro diagnostic (IVD) device had successfully passed its conformity assessment under the EU IVDR, secured manufacturing capacity, and established a detailed post-market performance follow-up plan before commercial release. - Following a software update for an existing medical device, the company confirmed that cybersecurity risk assessments were updated per FDA guidance on Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, and the updated software was verified and validated before deployment to market deployment. Common pitfalls - • Assuming regulatory clearance or approval alone signifies launch readiness without considering other critical elements. - • Failing to integrate regulatory and quality milestones into the overall launch readiness checklist. - • Underestimating the resources and time required for effective sales force training and post-market surveillance infrastructure. - • Neglecting to update launch readiness criteria based on evolving regulatory requirements or market conditions. ## Frequently asked questions How does launch readiness relate to a Quality Management System (QMS)? Launch readiness heavily relies on a mature QMS that ensures all design, manufacturing, and post-market activities comply with regulatory requirements. A QMS provides the documented processes and controls necessary to consistently produce [safe](/terms/safe-note) and effective devices, which is a prerequisite for market entry. What role does risk management play in launch readiness? Is launch readiness a one-time event? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Quality & Risk Design History File(DHF) Compilation of records describing the design history of a finished device. ](/terms/design-history-file)[ Post-Market Post-Market Surveillance(PMS) Activities to monitor device safety and performance after market release. ](/terms/post-market-surveillance) ### More in Commercialization · Same category [ Commercialization AdvaMed Code of Ethics Industry code governing interactions between U.S. medical-device companies and healthcare professionals. ](/terms/advamed-code)[ Commercialization Advisory Board Convening of external experts to advise on strategy or product. ](/terms/advisory-board)[ Commercialization Anti-Kickback Statute(AKS) U.S. criminal statute prohibiting remuneration to induce federal healthcare business. ](/terms/anti-kickback)[ Commercialization Bottom-Up Market Sizing Building market size from procedure volumes × price × penetration. ](/terms/bottom-up-sizing) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 AdvaMed· 2 AHRMM· 1 1. [1 AdvaMed product launch Verified AdvaMed · advamed.org ](https://www.advamed.org/) 2. [2 AdvaMed Code of Ethics Verified AdvaMed · advamed.org ](https://www.advamed.org/our-work/code-of-ethics/) 3. [3 AHRMM - Healthcare Supply Chain Verified AHRMM · ahrmm.org ](https://www.ahrmm.org/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Selling a connected device into health systems? Hospital procurement increasingly requires MDS2, SBOM, and security questionnaires - we help your team answer them confidently. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Commercialization Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=launch-readiness) Learn in 60 seconds Card Lesson Quiz Cross-functional checklist confirming a product is ready for commercial release. - · Missing any one element can stall launch. - · CMO, CCO, and Quality VP typically co-own the gate. Remember this Watch out: Assuming regulatory clearance or approval alone signifies launch readiness without considering other critical elements. Related terms - [Design History File(DHF) ](/terms/design-history-file) - [Post-Market Surveillance(PMS) ](/terms/post-market-surveillance) You may also need Auto-suggested from Commercialization and shared keywords. - [Milestone Payment ](/terms/milestone-payment) - [Post-Market Performance Follow-Up (IVDR)(PMPF) ](/terms/ivdr-pmpf) - [Series A / B / C Financing Rounds ](/terms/series-funding) - [Advisory Board ](/terms/advisory-board) - [Physician Training and Proctoring ](/terms/training-and-proctoring) - [Value Analysis Committee(VAC) ](/terms/vac) [All Commercialization terms](/terms?cat=Commercialization) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)